ACTAVIS MID ATLANTIC FDA Approval ANDA 201000

ANDA 201000

ACTAVIS MID ATLANTIC

FDA Drug Application

Application #201000

Documents

Letter2014-10-29

Application Sponsors

ANDA 201000ACTAVIS MID ATLANTIC

Marketing Status

Prescription001

Application Products

001GEL;TOPICAL0.3%0ADAPALENEADAPALENE

FDA Submissions

N/A; Not ApplicableORIG1AP2014-10-27

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

ACTAVIS MID ATLANTIC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 201000
            [companyName] => ACTAVIS MID ATLANTIC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ADAPALENE","activeIngredients":"ADAPALENE","strength":"0.3%","dosageForm":"GEL;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/27\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/201000Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-10-27
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.